![Ioannis ROUSSIS | Research Director | Professor | University of Ioannina, Ioánnina | UOI | Department of Chemistry Ioannis ROUSSIS | Research Director | Professor | University of Ioannina, Ioánnina | UOI | Department of Chemistry](https://www.researchgate.net/profile/Ioannis-Roussis/publication/250143705/figure/tbl1/AS:671519776714780@1537114199401/Inhibition-of-The-Oxidation-of-Corn-Oil-Stripped-of-Tocopherols-A234-nm-A270-nm-and_Q320.jpg)
Ioannis ROUSSIS | Research Director | Professor | University of Ioannina, Ioánnina | UOI | Department of Chemistry
![Resveratrol protects against oxidized low‑density lipoprotein‑induced human umbilical vein endothelial cell apoptosis via inhibition of mitochondrial‑derived oxidative stress Resveratrol protects against oxidized low‑density lipoprotein‑induced human umbilical vein endothelial cell apoptosis via inhibition of mitochondrial‑derived oxidative stress](https://www.spandidos-publications.com/article_images/mmr/15/5/MMR-15-05-2457-g01.jpg)
Resveratrol protects against oxidized low‑density lipoprotein‑induced human umbilical vein endothelial cell apoptosis via inhibition of mitochondrial‑derived oxidative stress
![Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0031942202004454-gr1.gif)
Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect
![Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000930841830001X-gr1.jpg)
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect
![Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000930841830001X-gr6.jpg)
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect
![Inhibition of LDL oxidation and inflammasome assembly by nitroaliphatic derivatives. Potential use as anti-inflammatory and anti-atherogenic agents - ScienceDirect Inhibition of LDL oxidation and inflammasome assembly by nitroaliphatic derivatives. Potential use as anti-inflammatory and anti-atherogenic agents - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523418308407-gr4.jpg)
Inhibition of LDL oxidation and inflammasome assembly by nitroaliphatic derivatives. Potential use as anti-inflammatory and anti-atherogenic agents - ScienceDirect
![Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0031942202004454-gr3.gif)
Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect
![Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000930841830001X-gr4.jpg)
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect
![Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000930841830001X-gr3.jpg)
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect
![Oxidized Low-Density Lipoprotein Suppresses Expression of Prostaglandin E Receptor Subtype EP3 in Human THP-1 Macrophages Oxidized Low-Density Lipoprotein Suppresses Expression of Prostaglandin E Receptor Subtype EP3 in Human THP-1 Macrophages](https://ndownloader.figstatic.com/files/1725640/preview/1725640/preview.jpg)
Oxidized Low-Density Lipoprotein Suppresses Expression of Prostaglandin E Receptor Subtype EP3 in Human THP-1 Macrophages
![Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000930841830001X-gr8.jpg)
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect
![Inhibition of LDL oxidation and inflammasome assembly by nitroaliphatic derivatives. Potential use as anti-inflammatory and anti-atherogenic agents - ScienceDirect Inhibition of LDL oxidation and inflammasome assembly by nitroaliphatic derivatives. Potential use as anti-inflammatory and anti-atherogenic agents - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523418308407-fx1.jpg)
Inhibition of LDL oxidation and inflammasome assembly by nitroaliphatic derivatives. Potential use as anti-inflammatory and anti-atherogenic agents - ScienceDirect
![Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000930841830001X-gr5.jpg)
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect
![Nrf2 is essential for cholesterol crystal‐induced inflammasome activation and exacerbation of atherosclerosis - Freigang - 2011 - European Journal of Immunology - Wiley Online Library Nrf2 is essential for cholesterol crystal‐induced inflammasome activation and exacerbation of atherosclerosis - Freigang - 2011 - European Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9b5eb14d-5ced-4519-ad17-2326f5bf6e98/mfig001.jpg)
Nrf2 is essential for cholesterol crystal‐induced inflammasome activation and exacerbation of atherosclerosis - Freigang - 2011 - European Journal of Immunology - Wiley Online Library
![Nutrients | Free Full-Text | Extra Virgin Olive Oil Phenol Extracts Exert Hypocholesterolemic Effects through the Modulation of the LDLR Pathway: In Vitro and Cellular Mechanism of Action Elucidation | HTML Nutrients | Free Full-Text | Extra Virgin Olive Oil Phenol Extracts Exert Hypocholesterolemic Effects through the Modulation of the LDLR Pathway: In Vitro and Cellular Mechanism of Action Elucidation | HTML](https://www.mdpi.com/nutrients/nutrients-12-01723/article_deploy/html/images/nutrients-12-01723-ag.png)
Nutrients | Free Full-Text | Extra Virgin Olive Oil Phenol Extracts Exert Hypocholesterolemic Effects through the Modulation of the LDLR Pathway: In Vitro and Cellular Mechanism of Action Elucidation | HTML
![Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease | Journal of Inflammation | Full Text Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease | Journal of Inflammation | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12950-019-0211-5/MediaObjects/12950_2019_211_Fig2_HTML.png)
Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease | Journal of Inflammation | Full Text
![Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology](https://molpharm.aspetjournals.org/content/molpharm/82/2/246/F4.large.jpg)
Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology
![Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology](https://molpharm.aspetjournals.org/content/molpharm/82/2/246/F6.large.jpg?width=800&height=600&carousel=1)
Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology
![Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0031942202004454-gr5.gif)